0.30 (-16.99%)
As of Nov 03, 2023
Source:
Frequency Therapeutics, Inc is a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person’s innate regenerative potential to restore function. Our focus is on advancing our lead product candidate, FX-322, through clinical studies with the goal of developing and commercializing a medicine to help millions of people with the most common form of hearing loss while continuing to broaden the potential of our regenerative approach in other applications.
Country | United States |
Headquarters | lexington, massachusetts |
Phone Number | 781-315-4600 |
Industry | manufacturing |
CEO | David L. Lucchino |
Website | www.clinicaltrials.gov |